Integral Ad Science Holding Corp. (NASDAQ:IAS) Position Lifted by Invenomic Capital Management LP

Invenomic Capital Management LP grew its holdings in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS) by 57.4% during the third quarter, Holdings Channel reports. The firm owned 585,309 shares of the company’s stock after acquiring an additional 213,488 shares during the quarter. Invenomic Capital Management LP’s holdings in Integral Ad Science were worth $6,327,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently modified their holdings of IAS. Crestwood Capital Management L.P. boosted its position in shares of Integral Ad Science by 0.3% during the 3rd quarter. Crestwood Capital Management L.P. now owns 650,738 shares of the company’s stock valued at $7,034,000 after purchasing an additional 1,941 shares in the last quarter. nVerses Capital LLC bought a new position in shares of Integral Ad Science during the 3rd quarter valued at about $45,000. Principal Financial Group Inc. boosted its position in shares of Integral Ad Science by 9.3% during the 2nd quarter. Principal Financial Group Inc. now owns 61,108 shares of the company’s stock valued at $594,000 after purchasing an additional 5,189 shares in the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of Integral Ad Science by 18.1% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 37,870 shares of the company’s stock valued at $368,000 after purchasing an additional 5,806 shares in the last quarter. Finally, III Capital Management boosted its position in shares of Integral Ad Science by 9.8% during the 2nd quarter. III Capital Management now owns 65,158 shares of the company’s stock valued at $633,000 after purchasing an additional 5,831 shares in the last quarter. 95.78% of the stock is owned by institutional investors and hedge funds.

Integral Ad Science Trading Up 3.2 %

NASDAQ:IAS opened at $11.54 on Tuesday. Integral Ad Science Holding Corp. has a 12 month low of $7.98 and a 12 month high of $17.53. The firm has a market cap of $1.88 billion, a price-to-earnings ratio of 57.70, a P/E/G ratio of 1.54 and a beta of 1.46. The company has a quick ratio of 3.71, a current ratio of 3.71 and a debt-to-equity ratio of 0.07. The company’s 50 day moving average is $11.09 and its 200-day moving average is $10.59.

Integral Ad Science (NASDAQ:IAS) last announced its quarterly earnings data on Tuesday, November 12th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.08 by $0.02. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The business had revenue of $133.50 million for the quarter, compared to the consensus estimate of $138.06 million. During the same quarter last year, the company posted ($0.09) earnings per share. Integral Ad Science’s quarterly revenue was up 11.0% on a year-over-year basis. Equities analysts anticipate that Integral Ad Science Holding Corp. will post 0.26 EPS for the current year.

Analyst Upgrades and Downgrades

IAS has been the subject of several recent analyst reports. Barclays raised their target price on shares of Integral Ad Science from $12.00 to $13.00 and gave the stock an “equal weight” rating in a report on Monday, August 5th. Piper Sandler decreased their target price on shares of Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating for the company in a report on Wednesday, November 13th. Truist Financial decreased their target price on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a report on Wednesday, November 13th. Benchmark reiterated a “hold” rating on shares of Integral Ad Science in a report on Thursday, November 14th. Finally, Craig Hallum decreased their price target on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a report on Wednesday, November 13th. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $15.70.

Insider Activity

In other Integral Ad Science news, CEO Lisa Utzschneider sold 10,481 shares of the business’s stock in a transaction dated Monday, October 7th. The stock was sold at an average price of $10.11, for a total transaction of $105,962.91. Following the completion of the sale, the chief executive officer now directly owns 239,709 shares of the company’s stock, valued at approximately $2,423,457.99. The trade was a 4.19 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Tania Secor sold 6,643 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $11.24, for a total value of $74,667.32. Following the completion of the sale, the chief financial officer now directly owns 251,366 shares of the company’s stock, valued at approximately $2,825,353.84. This trade represents a 2.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 23,006 shares of company stock worth $240,296. Corporate insiders own 2.00% of the company’s stock.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.